← Open Payments lookup

ALEXA WINTER: Open Payments

NPI 1023647872 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,027 in 38 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $32 · 2025 $1,027

Food & beverage: $827Education: $200
CompanyPaymentsAmount
Janssen Biotech, Inc.2$114
Daiichi Sankyo Inc.4$112
Alexion Pharmaceuticals, Inc.1$100
GENZYME CORPORATION2$61
Merck Sharp & Dohme LLC2$59
AstraZeneca Pharmaceuticals LP3$58
Pharmacosmos Therapeutics Inc.2$52
Adaptive Biotechnologies Corporation2$51
Bayer Healthcare Pharmaceuticals Inc.2$40
Astellas Pharma US Inc2$34

Products named: RYBREVANT, SOLIRIS, Enhertu, DATROWAY, MONOFERRIC, clonoSEQ, SARCLISA, VENCLEXTA.

Industry payments across IN — which companies pay providers there.